Skip to main content

Table 2 Overall survival for various characteristics based on Kaplan–Meier analysis

From: Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma

Variables Overall survival (d) mean (95 % CI) p
BMI   3.6 × 10−13
 <23 kg/m2 353.9 (316.9–391.0)  
 ≥23 kg/m2 571.8 (532.3–611.4)  
Age   0.924
 <60 years 444.9 (397.6–492.1)  
 ≥60 years 444.2 (406.8–481.5)  
Gender   0.537
 Male 451.9 (413.7–490.2)  
 Female 427.2 (382.8–471.6)  
Diabetes   0.563
 Yes 440.6 (408.3–474.0)  
 No 457.2 (388.0–526.5)  
Alcohol   0.453
 Ever 425.8 (369.4–482.1)  
 Never 451.4 (417.1–485.6)  
Smoking   0.085
 Ever 411.6 (362.2–461.1)  
 Never 462.1 (425.9–498.3)  
AFP   0.651
 ≥400 μg/L 456.8 (405.2–508.4)  
 <400 μg/L 433.7 (396.3–471.1)  
Viral status   0.349
 HBV 432.8 (396.0–469.6)  
 HCV 459.8 (408.3–511.3)  
Previous treatment   0.502
 Yes 459.8 (405.3–514.3)  
 No 432.7 (396.9–468.5)  
Child–Pugh class   3.6 × 10−31
 A class 627.1 (592.0–662.2)  
 B class 479.7 (435.0–524.5)  
 C class 232.0 (198.9–265.2)  
Extrahepatic metastasis   5.3 × 10−13
 Yes 202.4 (148.4–256.4)  
 No 471.2 (440.7–501.7)  
Infiltration of portal vein   1.4 × 10−13
 Yes 259.9 (228.0–290.8)  
 No 513.2 (479.2–547.1)  
Treatment after diagnosis   2.5 × 10–31
 Yes 617.2 (589.2–645.2)  
 No 259.7 (232.5–286.9)  
BCLC stage   1.4 × 10−36
 0 stage 696.3 (652.7–739.8)  
 1 stage 678.8 (653.2–704.4)  
 2 stage 544.8 (500.2–589.4)  
 3 stage 299.6 (257.9–341.2)  
 4 stage 232.0 (198.9–265.2)